About Poseida Therapeutics

Poseida Therapeutics is a spin out of Transposagen Biopharmaceuticals that utilizes best-in-class, proprietary genome editing technologies to develop targeted, life-saving therapeutics in areas of high unmet medical need. We have demonstrated proof-of-principle that validates the potential of our differentiated genome engineering technologies and their therapeutic applications. Our technology platforms have broad applicability and Poseida’s long-term goal is to apply its proprietary gene editing technologies to a broad range of human diseases. The initial applications of Poseida’s technologies will be in gene therapy and CAR-T product candidates for liver disorders and cancer, respectively.

website icon
Website
employees icon
Employees
industry icon
Industry
IT Services and IT Consulting
location icon
Headquarter
La Jolla, California
description icon
Founded
2015

Poseida Therapeutics Alternatives

Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics

Frequently Asked Questions about Poseida Therapeutics

Who are the decision makers in Poseida Therapeutics?

The decision makers in Poseida Therapeutics are Angie Schinkel, Carol Susla, Debbie Gessner, etc. Click to Find Poseida Therapeutics decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more